Orthofix Medical (OFIX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $9.38, -2.19% vs the prior close of $9.59.
- Volume 286.06K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OFIX dips 2.2% to $9.38. Closed at $9.38, -2.19% vs the prior close of $9.59. Day range $9.34–$9.81, opened at $9.64.
OFIX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — OFIX dips 2.2% to $9.38
- Closed at $9.38, -2.19% vs the prior close of $9.59. Day range $9.34–$9.81, opened at $9.64.
- Volume was 286.06K shares, 0.8x its 50-day average of 377.04K.
- Price is -1.1% vs its 50-day average ($9.48) and -17.5% vs its 200-day average ($11.37).
- 52-week range $8.50–$16.99; today's close sits at 10% of that range, 44.8% below the 52-week high.
Oct 15, 2026 — OFIX jumps 3.7% to $9.59
- Closed at $9.59, +3.68% vs the prior close of $9.25. Day range $9.35–$9.72, opened at $9.42.
- Volume was 318.00K shares, 0.8x its 50-day average of 394.55K.
- Price is +0.9% vs its 50-day average ($9.50) and -15.9% vs its 200-day average ($11.40).
- 52-week range $8.50–$16.99; today's close sits at 13% of that range, 43.6% below the 52-week high.
Oct 14, 2026 — OFIX ends flat (-0.1%) to $9.25
- Closed at $9.25, -0.11% vs the prior close of $9.26. Day range $9.15–$9.30, opened at $9.24.
- Volume was 292.20K shares, 0.7x its 50-day average of 396.96K.
- Price is -2.9% vs its 50-day average ($9.52) and -19.1% vs its 200-day average ($11.43).
- 52-week range $8.50–$16.99; today's close sits at 9% of that range, 45.6% below the 52-week high.
Oct 13, 2026 — OFIX ends flat (-0.2%) to $9.26
- Closed at $9.26, -0.22% vs the prior close of $9.28. Day range $8.99–$9.49, opened at $9.38.
- Volume was 483.70K shares, 1.2x its 50-day average of 395.65K.
- Price is -3.3% vs its 50-day average ($9.58) and -19.2% vs its 200-day average ($11.46).
- 52-week range $8.50–$16.99; today's close sits at 9% of that range, 45.5% below the 52-week high.
Oct 12, 2026 — OFIX rises 1.2% to $9.28
- Closed at $9.28, +1.20% vs the prior close of $9.17. Day range $9.12–$9.30, opened at $9.15.
- Volume was 336.20K shares, 0.9x its 50-day average of 394.15K.
- Price is -3.7% vs its 50-day average ($9.64) and -19.3% vs its 200-day average ($11.49).
- 52-week range $8.50–$16.99; today's close sits at 9% of that range, 45.4% below the 52-week high.
Oct 9, 2026 — OFIX rises 1.9% to $9.17
- Closed at $9.17, +1.89% vs the prior close of $9.00. Day range $8.99–$9.24, opened at $9.00.
- Volume was 314.20K shares, 0.8x its 50-day average of 392.72K.
- Price is -5.4% vs its 50-day average ($9.69) and -20.4% vs its 200-day average ($11.52).
- 52-week range $8.50–$16.99; today's close sits at 8% of that range, 46.0% below the 52-week high.
Oct 8, 2026 — OFIX dips 2.2% to $9.00, 3 down days in a row
- Closed at $9.00, -2.17% vs the prior close of $9.20. Day range $8.86–$9.30, opened at $9.18.
- Volume was 588.10K shares, 1.5x its 50-day average of 388.55K.
- Price is -7.6% vs its 50-day average ($9.74) and -22.1% vs its 200-day average ($11.55).
- 52-week range $8.50–$16.99; today's close sits at 6% of that range, 47.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — OFIX dips 2.2% to $9.20
- Closed at $9.20, -2.23% vs the prior close of $9.41. Day range $9.18–$9.57, opened at $9.33.
- Volume was 394.40K shares, 1.0x its 50-day average of 386.02K.
- Price is -6.2% vs its 50-day average ($9.81) and -20.6% vs its 200-day average ($11.58).
- 52-week range $8.50–$16.99; today's close sits at 8% of that range, 45.9% below the 52-week high.
Oct 6, 2026 — OFIX dips 0.9% to $9.41
- Closed at $9.41, -0.95% vs the prior close of $9.50. Day range $9.38–$9.59, opened at $9.53.
- Volume was 392.80K shares, 1.0x its 50-day average of 383.86K.
- Price is -4.6% vs its 50-day average ($9.87) and -19.0% vs its 200-day average ($11.62).
- 52-week range $8.50–$16.99; today's close sits at 11% of that range, 44.6% below the 52-week high.
Oct 5, 2026 — OFIX jumps 4.5% to $9.50
- Closed at $9.50, +4.51% vs the prior close of $9.09. Day range $9.01–$9.54, opened at $9.09.
- Volume was 634.60K shares, 1.7x its 50-day average of 375.95K.
- Price is -4.2% vs its 50-day average ($9.92) and -18.4% vs its 200-day average ($11.65).
- 52-week range $8.50–$16.99; today's close sits at 12% of that range, 44.1% below the 52-week high.
Oct 2, 2026 — OFIX dips 1.3% to $9.09, 4 down days in a row
- Closed at $9.09, -1.30% vs the prior close of $9.21. Day range $9.07–$9.33, opened at $9.26.
- Volume was 319.20K shares, 0.9x its 50-day average of 373.19K.
- Price is -8.7% vs its 50-day average ($9.95) and -22.2% vs its 200-day average ($11.68).
- 52-week range $8.50–$16.99; today's close sits at 7% of that range, 46.5% below the 52-week high.
- That makes 4 straight losses.
OFIX latest news & SEC filings
Every SEC filing by or about OFIX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Fisher Patrick sold 150 shares at $9.44 (≈$1.42K) on Oct 1, 2026; now holds 50,919
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Juniper Investment Company, Llc & Bartholdson John A. & Michas Alexis P bought 120,000 shares at $8.74 (≈$1.05M) on Sep 18, 2026; now holds 3,581,216
- Juniper Investment Company, Llc & Bartholdson John A. & Michas Alexis P bought 190,000 shares at $8.86 (≈$1.68M) on Sep 21, 2026; now holds 3,771,216
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Juniper Investment Company, Llc & Bartholdson John A. & Michas Alexis P sold 120,000 shares at $8.74 (≈$1.05M) on Sep 18, 2026; now holds 3,581,216
- Juniper Investment Company, Llc & Bartholdson John A. & Michas Alexis P sold 190,000 shares at $8.86 (≈$1.68M) on Sep 21, 2026; now holds 3,771,216
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $210.93M (prior year $203.12M) (+3.8% vs Jun 30, 2025)
- Net income: -$15.80M (prior year -$14.08M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.39 (prior year -$0.36) (loss widened vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade OFIX
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Apr 9, 2026, Feb 24, 2026. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.99% (largest 4.5%).
- Liquidity: about 439.81K shares (≈$4.13M) trade per day on average.
- 52-week position: $9.38 vs a range of $8.50–$16.99 (10% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 13 open-market buys, 12 sales; latest: John A. Bartholdson bought 190,000 shares on Sep 21, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jul 2, 2026.
- Share count: 40.73M shares outstanding (Jul 31, 2026), +3.1% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
OFIX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9.64 | 9.81 | 9.34 | 9.38 | 286.06K |
| Oct 15, 2026 | 9.42 | 9.72 | 9.35 | 9.59 | 318.00K |
| Oct 14, 2026 | 9.24 | 9.30 | 9.15 | 9.25 | 292.20K |
| Oct 13, 2026 | 9.38 | 9.49 | 8.99 | 9.26 | 483.70K |
| Oct 12, 2026 | 9.15 | 9.30 | 9.12 | 9.28 | 336.20K |
| Oct 9, 2026 | 9.00 | 9.24 | 8.99 | 9.17 | 314.20K |
| Oct 8, 2026 | 9.18 | 9.30 | 8.86 | 9.00 | 588.10K |
| Oct 7, 2026 | 9.33 | 9.57 | 9.18 | 9.20 | 394.40K |
| Oct 6, 2026 | 9.53 | 9.59 | 9.38 | 9.41 | 392.80K |
| Oct 5, 2026 | 9.09 | 9.54 | 9.01 | 9.50 | 634.60K |
| Oct 2, 2026 | 9.26 | 9.33 | 9.07 | 9.09 | 319.20K |
| Oct 1, 2026 | 9.44 | 9.57 | 9.16 | 9.21 | 525.30K |
| Sep 30, 2026 | 9.75 | 9.75 | 9.38 | 9.41 | 588.00K |
| Sep 29, 2026 | 9.80 | 9.82 | 9.49 | 9.75 | 433.80K |
| Sep 28, 2026 | 9.33 | 9.87 | 9.19 | 9.84 | 438.10K |
| Sep 25, 2026 | 9.21 | 9.94 | 9.12 | 9.44 | 743.70K |
| Sep 24, 2026 | 9.23 | 9.35 | 8.99 | 9.16 | 439.00K |
| Sep 23, 2026 | 9.02 | 9.27 | 8.88 | 9.18 | 437.70K |
| Sep 22, 2026 | 9.04 | 9.21 | 8.95 | 8.98 | 256.90K |
| Sep 21, 2026 | 8.72 | 8.98 | 8.57 | 8.95 | 574.30K |
About Orthofix Medical
Orthofix Medical (OFIX) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in LEWISVILLE, TX. Fiscal year ends December 23. SEC CIK 884624.
OFIX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Wayne Burris | Director | Jun 12, 2026 |
| Alan Lee Bazaar | Director | Jun 12, 2026 |
| Vickie L Capps | Director | Jun 12, 2026 |
| Massimo Calafiore | President & CEO | Mar 6, 2026 |
| Michael Finegan | Director | Jun 12, 2026 |
| John B Iii Henneman | Director | Jun 12, 2026 |
| Jason Hannon | Director | Jun 12, 2026 |
| Charles R. Kummeth | Director | Jun 12, 2026 |
| Shweta Maniar | Director | Jun 12, 2026 |
| Michael E Paolucci | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Julie Andrews | CFO | Mar 6, 2026 |
| Massimo Calafiore | President & CEO | Mar 6, 2026 |
| Jorge Andres Cedron | CLO | Apr 20, 2026 |
| Patrick Fisher | President, Global Limb Recon | Sep 3, 2026 |
| Aviva Mcpherron | Pres, Global Ops & Qual | Jun 22, 2026 |
| Max Reinhardt | President, Global Spine | Mar 6, 2026 |
| Lucas Vitale | CP&BOO | Mar 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 21, 2026 | John A. Bartholdson | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | John A. Bartholdson | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | Investment Company, Llc Juniper | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | Investment Company, Llc Juniper | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | Alexis P Michas | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | Alexis P Michas | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | John A. Bartholdson | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | John A. Bartholdson | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | Investment Company, Llc Juniper | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | Investment Company, Llc Juniper | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | Alexis P Michas | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | Alexis P Michas | Buy | 190,000 | $8.86 |
| Sep 21, 2026 | Investment Company, Llc Juniper | Sale | 190,000 | $8.86 |
| Sep 21, 2026 | Investment Company, Llc Juniper | Sale | 190,000 | $8.86 |
| Sep 21, 2026 | John A. Bartholdson | Sale | 190,000 | $8.86 |
OFIX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $822.31M | $-92.19M | -2.33 | $33.35M |
| Dec 31, 2024 | $799.49M | $-126.00M | -3.30 | $25.79M |
| Dec 31, 2023 | $746.64M | $-151.40M | -4.12 | $-45.75M |
| Dec 31, 2022 | $460.71M | $-19.75M | -0.98 | $-11.54M |
| Dec 31, 2021 | $464.48M | $-38.38M | -1.95 | $18.48M |
Latest balance sheet: total assets $873.02M, total liabilities $443.84M, cash $103.81M (as of Jun 30, 2026).
OFIX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $10.42 |
| May 5, 2026 | 8-K Item 2.02 (results) | $12.44 |
| Apr 9, 2026 | 8-K Item 2.02 (results) | $12.42 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $12.75 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $14.87 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $12.31 |
| May 6, 2025 | 8-K Item 2.02 (results) | $12.06 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $17.51 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $18.22 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 5, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on OFIX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.